Literature DB >> 14618633

Mutations of BRAF and KRAS in gastric cancer and their association with microsatellite instability.

Wei Zhao, Tsun Leung Chan, Kent-Man Chu, Annie S Chan, Michael R Stratton, Siu Tsan Yuen, Suet Yi Leung.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 14618633     DOI： 10.1002/ijc.11553

Source DB:  PubMed          Journal:  Int J Cancer        ISSN： 0020-7136            Impact factor:   7.396


× No keyword cloud information.
  16 in total

Review 1.  Causes and consequences of microsatellite instability in gastric carcinogenesis.

Authors:  Sérgia Velho; Maria Sofia Fernandes; Marina Leite; Ceu Figueiredo; Raquel Seruca
Journal:  World J Gastroenterol       Date:  2014-11-28       Impact factor: 5.742

Review 2.  Anti-HER agents in gastric cancer: from bench to bedside.

Authors:  Lorenzo Fornaro; Maurizio Lucchesi; Chiara Caparello; Enrico Vasile; Sara Caponi; Laura Ginocchi; Gianluca Masi; Alfredo Falcone
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2011-06-07       Impact factor: 46.802

3.  Is gastric cancer part of the tumour spectrum of hereditary non-polyposis colorectal cancer? A molecular genetic study.

Authors:  A Gylling; W M Abdel-Rahman; M Juhola; K Nuorva; E Hautala; H J Järvinen; J-P Mecklin; M Aarnio; P Peltomäki
Journal:  Gut       Date:  2007-01-31       Impact factor: 23.059

4.  Identification of HRAS as cancer-promoting gene in gastric carcinoma cell aggressiveness.

Authors:  Xiao Yu Wu; Wen Tao Liu; Zhen Feng Wu; Che Chen; Jia Yun Liu; Guan Nan Wu; Xue Quan Yao; Fu Kun Liu; Gang Li
Journal:  Am J Cancer Res       Date:  2016-09-01       Impact factor: 6.166

5.  Inhibition of AURKA Reduces Proliferation and Survival of Gastrointestinal Cancer Cells With Activated KRAS by Preventing Activation of RPS6KB1.

Authors:  Lihong Wang-Bishop; Zheng Chen; Ahmed Gomaa; Albert Craig Lockhart; Safia Salaria; Jialiang Wang; Keeli B Lewis; Jeffrey Ecsedy; Kay Washington; Robert Daniel Beauchamp; Wael El-Rifai
Journal:  Gastroenterology       Date:  2018-10-17       Impact factor: 22.682

6.  Mutations of PIK3CA in gastric adenocarcinoma.

Authors:  Vivian Sze Wing Li; Chi Wai Wong; Tsun Leung Chan; Agnes Sze Wah Chan; Wei Zhao; Kent-Man Chu; Samuel So; Xin Chen; Siu Tsan Yuen; Suet Yi Leung
Journal:  BMC Cancer       Date:  2005-03-23       Impact factor: 4.430

7.  Mixed lineage kinase 3 gene mutations in mismatch repair deficient gastrointestinal tumours.

Authors:  Sérgia Velho; Carla Oliveira; Joana Paredes; Sónia Sousa; Marina Leite; Paulo Matos; Fernanda Milanezi; Ana Sofia Ribeiro; Nuno Mendes; Danilo Licastro; Auli Karhu; Maria José Oliveira; Marjolijn Ligtenberg; Richard Hamelin; Fátima Carneiro; Annika Lindblom; Paivi Peltomaki; Sérgio Castedo; Simó Schwartz; Peter Jordan; Lauri A Aaltonen; Robert M W Hofstra; Gianpaolo Suriano; Elia Stupka; Arsenio M Fialho; Raquel Seruca
Journal:  Hum Mol Genet       Date:  2009-12-02       Impact factor: 6.150

8.  Cetuximab plus oxaliplatin/leucovorin/5-fluorouracil in first-line metastatic gastric cancer: a phase II study of the Arbeitsgemeinschaft Internistische Onkologie (AIO).

Authors:  F Lordick; B Luber; S Lorenzen; S Hegewisch-Becker; G Folprecht; E Wöll; T Decker; E Endlicher; N Röthling; T Schuster; G Keller; F Fend; C Peschel
Journal:  Br J Cancer       Date:  2010-01-12       Impact factor: 7.640

Review 9.  The genomic architecture of metastasis in breast cancer: focus on mechanistic aspects, signalling pathways and therapeutic strategies.

Authors:  Yogita Chhichholiya; Prabhat Suman; Sandeep Singh; Anjana Munshi
Journal:  Med Oncol       Date:  2021-07-16       Impact factor: 3.064

10.  KRAS and BRAF mutations are rare and related to DNA mismatch repair deficiency in gastric cancer from the East and the West: results from a large international multicentre study.

Authors:  N C T van Grieken; T Aoyama; T Aoyma; P A Chambers; D Bottomley; L C Ward; I Inam; T E Buffart; K Das; T Lim; B Pang; S L Zhang; I B Tan; B Carvalho; D A M Heideman; Y Miyagi; Y Kameda; T Arai; G A Meijer; A Tsuburaya; P Tan; T Yoshikawa; H I Grabsch
Journal:  Br J Cancer       Date:  2013-03-19       Impact factor: 7.640
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.